Skip to main content
OpenTrials

Clinical trial condition

Secondary Progressive Multiple Sclerosis

Explore clinical trials studying Secondary Progressive Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

42 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Secondary Progressive Multiple Sclerosis trial results

Completed

Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC)

NCT04792567

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, COVID-19, +22 more
Locations
  • Novartis Investigative Site Mittweida, Saxony, Germany
  • Novartis Investigative Site Bogen, Germany
  • Novartis Investigative Site Chemnitz, Germany
  • Novartis Investigative Site Dresden, Germany
View Trial Details
Completed

Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)

NCT01665144

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Berkeley, California, United States
  • Novartis Investigative Site Los Angeles, California, United States
  • Novartis Investigative Site Oceanside, California, United States
View all 290 locations
View Trial Details
Completed

Novel Imaging Markers in SPMS

NCT05357833

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +11 more
Locations
  • University of Utah Health Imaging and Neurosciences Center Salt Lake City, Utah, United States
View Trial Details
Completed

Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis

NCT02330965

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Jordan Research & Education Institute: Sutter Alta Bates Summit Berkeley, California, United States
  • University of Southern California Los Angeles, California, United States
  • University of California, Davis Sacramento, California, United States
  • University of Colorado Aurora, Colorado, United States
View all 13 locations
View Trial Details

Related conditions